Development and validation of an LC-MS/MS method for determination of compound K in human plasma and clinical application

Journal of Ginseng Research

Volumn 37, Issue 1, 2013, Pages 135-141

  Kim, Jung Soo ^a,b   Kim, Yunjeong ^a   Han, Song Hee ^a   Jeon, Ji Young ^a   Hwang, Minho ^a   Im, Yong Jin ^a   Kim, Jung Hyun ^a   Lee, Sun Young ^a   Chae, Soo Wan ^a   Kim, Min Gul ^a,b  

^a Chonbuk National University Medical School   (South Korea)

^b Chonbuk National University   (South Korea)

Author keywords

Compound K; Fermented Korean red ginseng; LC MS MS; Panax ginseng; Pharmacokinetics

Indexed keywords

BACTERIA (MICROORGANISMS); PANAX GINSENG;

EID: 84872247255     PISSN: 12268453     EISSN: None     Source Type: Journal    
DOI: 10.5142/jgr.2013.37.135     Document Type: Article

References (28)

1. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999;58:1685-1693.
2. Hasegawa H, Sung JH, Matsumiya S, Uchiyama M. Main ginseng saponin metabolites formed by intestinal bacteria. Planta Med 1996;62:453-457.
3. Hasegawa H, Sung JH, Benno Y. Role of human intestinal Prevotella oris in hydrolyzing ginseng saponins. Planta Med 1997;63:436-440.
4. Park CS, Yoo MH, Noh KH, Oh DK. Biotransformation of ginsenosides by hydrolyzing the sugar moieties of ginsenosides using microbial glycosidases. Appl Microbiol Biotechnol 2010;87:9-19.
5. Choi JR, Hong SW, Kim YR, Jang SE, Kim NJ, Han MJ, Kim DH. Metabolic activities of ginseng and its constituents, ginsenoside Rb1 and Rg1, by human intestinal microflora. J Ginseng Res 2011;35:301-307.
6. Quan LH, Piao JY, Min JW, Kim HB, Kim SR, Yang DU, Yang DC. Biotransformation of ginsenoside Rb1 to prosapogenins, gypenoside XVII, ginsenoside Rd, ginsenoside F2, and compound K by Leuconostoc mesenteroides DC 102. J Ginseng Res 2011;35:344-351.
7. Wakabayashi C, Murakami K, Hasegawa H, Murata J, Saiki I. An intestinal bacterial metabolite of ginseng protopanaxadiol saponins has the ability to induce apoptosis in tumor cells. Biochem Biophys Res Commun 1998;246:725-730.
8. Lee JY, Shin JW, Chun KS, Park KK, Chung WY, Bang YJ, Sung JH, Surh YJ. Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol-type ginsenosides in mouse skin. Carcinogenesis 2005;26:359-367.
9. Matsunaga H, Katano M, Yamamoto H, Mori M, Takata K. Studies on the panaxytriol of Panax ginseng C. A. Meyer. Isolation, determination and antitumor activity. Chem Pharm Bull (Tokyo) 1989;37:1279-1281.
10. Park EK, Shin YW, Lee HU, Kim SS, Lee YC, Lee BY, Kim DH. Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosyntheses of RAW264.7 cells induced by lipopolysaccharide. Biol Pharm Bull 2005;28:652-656.
11. Cuong TT, Yang CS, Yuk JM, Lee HM, Ko SR, Cho BG, Jo EK. Glucocorticoid receptor agonist compound K regulates Dectin-1-dependent inflammatory signaling through inhibition of reactive oxygen species. Life Sci 2009;85:625-633.
12. Han GC, Ko SK, Sung JH, Chung SH. Compound K enhances insulin secretion with beneficial metabolic effects in db/db mice. J Agric Food Chem 2007;55:10641-10648.
13. Yoon SH, Han EJ, Sung JH, Chung SH. Anti-diabetic effects of compound K versus metformin versus compound K-metformin combination therapy in diabetic db/db mice. Biol Pharm Bull 2007;30:2196-2200.
14. Bae EA, Choo MK, Park EK, Park SY, Shin HY, Kim DH. Metabolism of ginsenoside R(c) by human intestinal bacteria and its related antiallergic activity. Biol Pharm Bull 2002;25:743-747.
15. Choo MK, Park EK, Han MJ, Kim DH. Antiallergic activity of ginseng and its ginsenosides. Planta Med 2003;69:518-522.
16. Kevers C, Jacques P, Gaspar T, Thonart P, Dommes J. Comparative titration of ginsenosides by different techniques in commercial ginseng products and callus cultures. J Chromatogr Sci 2004;42:554-558.
17. Zhou W, Li J, Li X, Yan Q, Zhou P. Development and validation of a reversed-phase HPLC method for quantitative determination of ginsenosides Rb1, Rd, F2, and compound K during the process of biotransformation of ginsenoside Rb1. J Sep Sci 2008;31:921-925.
18. Sha DX, Zhang ML. Determination of notoginsenoside R1, ginsenoside Rg1 and Rb1 in Radix Notoginseng and its preparation by HPLC-ELSD. Zhongguo Zhong Yao Za Zhi 2005;30:112-115.
19. Xu ZX, Xiao HB, Wang JN, Liang XM. Analysis of ginsenosides by high performance liquid chromatography/mass spectrometry/mass spectrometry(LC/MS/MS). Se Pu 2000;18:521-524.
20. Li L, Sheng Y, Zhang J, Wang C, Guo D. HPLC determination of four active saponins from Panax notoginseng in rat serum and its application to pharmacokinetic studies. Biomed Chromatogr 2004;18:849-856.
21. Gu Y, Wang GJ, Sun JG, Jia YW, Xie HT, Wang W. Quantitative determination of ginsenoside Rh2 in rat bio-samples by liquid chromatography electrospray ionization mass spectrometry. Anal Bioanal Chem 2006;386:2043-2053.
22. Akao T, Kanaoka M, Kobashi K. Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administration: measurement of compound K by enzyme immunoassay. Biol Pharm Bull 1998;21:245-249.
23. Tachikawa E, Kudo K. Proof of the mysterious efficacy of ginseng: basic and clinical trials: suppression of adrenal medullary function in vitro by ginseng. J Pharmacol Sci 2004;95:140-144.
24. Karikura M, Miyase T, Tanizawa H, Taniyama T, Takino Y. Studies on absorption, distribution, excretion and metabolism of ginseng saponins. VII. Comparison of the decomposition modes of ginsenoside-Rb1 and-Rb2 in the digestive tract of rats. Chem Pharm Bull (Tokyo) 1991;39:2357-2361.
25. Tawab MA, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M. Degradation of ginsenosides in humans after oral administration. Drug Metab Dispos 2003;31:1065-1071.
26. Noh KH, Son JW, Kim HJ, Oh DK. Ginsenoside compound K production from ginseng root extract by a thermostable beta-glycosidase from Sulfolobus solfataricus. Biosci Biotechnol Biochem 2009;73:316-321.
27. Wang CZ, Kim KE, Du GJ, Qi LW, Wen XD, Li P, Bauer BA, Bissonnette MB, Musch MW, Chang EB, Yuan CS. Ultra-performance liquid chromatography and time-of-flight mass spectrometry analysis of ginsenoside metabolites in human plasma. Am J Chin Med 2011;39:1161-1171.
28. Paek IB, Moon Y, Kim J, Ji HY, Kim SA, Sohn DH, Kim JB, Lee HS. Pharmacokinetics of a ginseng saponin metabolite compound K in rats. Biopharm Drug Dispos 2006;27:39-45.